APA (7th ed.) Citation

L, M., M, A., VL, R., AP, A., NV, P., A, L., & JC, J. (2026). Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency. Journal of vascular surgery. Venous and lymphatic disorders, 14(5), 102557. https://doi.org/10.1016/j.jvsv.2026.102557

Chicago Style (17th ed.) Citation

L, Micalo, Archie M, Rowe VL, Adewale AP, Pham NV, Li A, and Jimenez JC. "Glucagon-like Peptide-1 Receptor Agonists Are Associated with Fewer Venous Thromboembolic Events and Limb Complications in Obese Patients with Chronic Venous Insufficiency." Journal of Vascular Surgery. Venous and Lymphatic Disorders 14, no. 5 (2026): 102557. https://doi.org/10.1016/j.jvsv.2026.102557.

MLA (9th ed.) Citation

L, Micalo, et al. "Glucagon-like Peptide-1 Receptor Agonists Are Associated with Fewer Venous Thromboembolic Events and Limb Complications in Obese Patients with Chronic Venous Insufficiency." Journal of Vascular Surgery. Venous and Lymphatic Disorders, vol. 14, no. 5, 2026, p. 102557, https://doi.org/10.1016/j.jvsv.2026.102557.